Press "Enter" to skip to content

New patent for Neurocrine drug INGREZZA

1
Copyright © DrugPatentWatch. Originally published at New patent for Neurocrine drug INGREZZA

Annual Drug Patent Expirations for INGREZZA
Annual Drug Patent Expirations for INGREZZA

Ingrezza is a drug marketed by Neurocrine and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.

This drug has eigthy-one patent family members in twenty-one countries.

The generic ingredient in INGREZZA is valbenazine tosylate. One supplier is listed for this compound. Additional details are available on the valbenazine tosylate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Neurocrine drug INGREZZA

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions